Drugs for the Prevention and Control of Syncope

Barbey JT. Syncope. Cardiology Clinics (Saunders) 1997;15:251-256.

Schatz LI. Autonomic failure and orthostatic hypotension. Hospital Practice 1997(May 15):15-20.

Kenny RA, Ingram A, Bayless J, et al. Head up tilt: A useful test for investigating unexplained syncope. Lancet 1986;1:1352-1355.

Sheldon R, Rose S, Flanagan P, et al. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 1996;93:973-981.

Almquist A, Goldenberg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989;320:346-351.

Cox MM, Perlman BA, Mayor MR, et al. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol 1995;26:1293-1298.

Sheldon R, Rose S, Flanagan P, et al. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 1996;78:536-539.

Milstein S, Buetikofer J, Dunnigan A, et al. Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 1990;65:1339-1344.

Morillo CA, Leitch JW, Yee R, et al. A placebo controlled trial of intravenous and oral disopyramide for the prevention of neurally-mediated syncope induced by headup tilt. J Am Coll Cardiol 1993;22:1843-1848.

Grubb BP, Wolfe DA, Samoil D, et al. Usefulness of fluoxetine hydrochloride in the treatment of resistant upright tilt-induced syncope. Pacing Clin Electrophysiol 1993;16:458-464.

Grubb BP, Samoil D, Kosinski D, et al. The use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 1994;24:490-494.

Dan D, Grubb BP, Mouhaffel A, et al. Preliminary observations on the use of nefazodone, a new selective 5-HT2A receptor blocker in the treatment of neurally mediated syncope. Eur J Cardiac Pacing Electrophysiol 1996;6:89-94.

Di Girolamo E, Di Iorio C, Sabatini P, et al. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: A randomized, double-blind, placebocontrolled study. J Am Coll Cardiol 1999;33:1227-1230.

Raviele A, Brignole M, Sutton R, et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope. A double-blind, randomized, placebo controlled trial. Circulation 1999;99:1452-1457.

Ward CR, Gray JC, Gilroy JJ, et al. Midodrine: A role in the management of neurocardiogenic syncope. Heart 1998;79:45-49.

Sra JS, Jazayeri MR, Avitall B, et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993;328:1085-1090.

Connolly SJ, Sheldon R, Roberts R, et al. The North American vasovagal pacemaker study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J AmColl Cardiol 1999;33:16-20.

Di Girolamo E, Do Iorio C, Leonzio L, et al. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents. A controlled study. Circulation 1999;100:1798-1801.

Reybrouck T, Heidbüchel, Van De Werf F, et al. Tilt training: A treatment for malignant and recurrent Neurocardiogenic syncope. PACE 2000;23[Pt. I]: 493-498.